知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

25 条记录 (耗时 0.025 秒)

    Artificial tissue constructs comprising alveolar cells and methods for using the same
    5.
    发明授权
    Artificial tissue constructs comprising alveolar cells and methods for using the same 有权
    包含肺泡细胞的人造组织构建体及其使用方法

    公开(公告)号：US08647837B2

    公开(公告)日：2014-02-11

    申请号：US12173921

    申请日：2008-07-16

    申请人： Ayesha Mahmood ,  Anatoly Kachurin ,  William Warren ,  Russell Higbee

    发明人： Ayesha Mahmood ,  Anatoly Kachurin ,  William Warren ,  Russell Higbee

    IPC分类号： C12Q1/68 ,  G01N33/53 ,  C12Q1/02

    CPC分类号： A61K9/70 ,  A61K35/17 ,  A61K35/36 ,  C12N5/0688 ,  C12N2502/28 ,  C12N2533/54 ,  G01N33/5082 ,  G01N2800/12

    摘要： The present invention comprises artificial tissue constructs that serve as in vitro models of mammalian lung tissue. The artificial tissue constructs of the present invention comprise functionally equivalent in vitro tissue scaffolds that enable immunophysiological function of the lung. The constructs can serve as novel platforms for the study of lung diseases (e.g., interstitial lung diseases, fibrosis, influenza, RSV) as well as smoke- and smoking-related diseases. The artificial tissue constructs of the present invention comprise the two components of alveolar tissue, epithelial and endothelial cell layers.

    摘要翻译： 本发明包括用作哺乳动物肺组织的体外模型的人造组织构建体。 本发明的人造组织构建体包括能够实现肺的免疫生理功能的功能上等同的体外组织支架。 这些构建体可以作为研究肺部疾病（例如间质性肺疾病，纤维化，流感，RSV）以及吸烟和吸烟相关疾病的新平台。 本发明的人造组织构建体包含肺泡组织，上皮和内皮细胞层的两个组分。

    IN VITRO UROGENITAL CO-CULTURE MODELS
    6.
    发明申请
    IN VITRO UROGENITAL CO-CULTURE MODELS 审中-公开
    在体外协同文化模式

    公开(公告)号：US20120156670A1

    公开(公告)日：2012-06-21

    申请号：US13296695

    申请日：2011-11-15

    申请人： Ayesha MAHMOOD ,  Melissa M. HERBST-KRALOVETZ ,  William WARREN

    发明人： Ayesha MAHMOOD ,  Melissa M. HERBST-KRALOVETZ ,  William WARREN

    IPC分类号： C12Q1/70 ,  C12Q1/02

    CPC分类号： C12N5/0683 ,  C12N5/0697 ,  C12N2502/1121 ,  C12N2502/246 ,  C12N2502/28 ,  C12N2503/04 ,  C12N2525/00 ,  C12N2531/00 ,  C12N2533/54 ,  C12N2533/70 ,  G01N33/5044 ,  G01N33/54313 ,  G01N2500/10

    摘要： The invention is directed to co-culture systems comprising (i) rotating wall vessel (RWV)-cultured epithelial or differentiated tissue attached to microcarrier beads and (ii) the peripheral tissue equivalent (PTE) module of the MIMIC® system, and to methods of using the co-culture systems for assessing chemical or biological (bacterial or viral) insults. The system models mucosal exposure to chemicals, pathogens or antigen at various sites in the human body. The microcarrier and MIMIC® co-culture approach provides an in vitro co-culture model that simultaneously demonstrates mucosa-mediated antigen presentation and immunogenic responses. Models of the present invention can be used, for example, in assessments of disease pathogenesis and in pharmaceutical development, reproductive physiology, and immunological and toxicological evaluations. Models of the present invention can generate patient-specific localized mucosal immunology using primary cells, resembling the human physiological situation.

    摘要翻译： 本发明涉及共培养系统，其包括（i）旋转连接到微载体珠的培养的上皮细胞或分化组织的旋转壁容器（RWV）和（ii）MIMIC系统的外周组织等价物（PTE）模块，以及方法 使用共培养系统来评估化学或生物（细菌或病毒）侮辱。 该系统模拟人体各个部位的化学物质，病原体或抗原的粘膜暴露。 微载体和MIMIC®共培养方法提供体外共培养模型，其同时显示粘膜介导的抗原呈递和免疫原性反应。 本发明的模型可以用于例如疾病发病机理和药物开发，生殖生理学和免疫学和毒理学评估中的评估。 本发明的模型可以使用类似于人类生理情况的原代细胞产生患者特异性局部粘膜免疫学。

    Surface-assisted hemagglutination and hemagglutination inhibition assays
    10.
    发明授权
    Surface-assisted hemagglutination and hemagglutination inhibition assays 有权
    表面辅助血细胞凝集和血细胞凝集抑制试验

    公开(公告)号：US08962256B2

    公开(公告)日：2015-02-24

    申请号：US12908211

    申请日：2010-10-20

    申请人： Anatoly Kachurin ,  Vaughan Wittman ,  Mike N. Nguyen ,  Olga Kachurina ,  Tenekua Tapia ,  Vipra Dhir ,  Alexander Karol

    发明人： Anatoly Kachurin ,  Vaughan Wittman ,  Mike N. Nguyen ,  Olga Kachurina ,  Tenekua Tapia ,  Vipra Dhir ,  Alexander Karol

    IPC分类号： G01N33/53 ,  G01N33/555 ,  G01N33/569 ,  G01N33/543

    CPC分类号： G01N33/56983 ,  G01N33/54353 ,  G01N33/54393 ,  G01N33/555

    摘要： Hemagglutination (HA) and hemagglutination inhibition (HAI) functional assays remain important instruments of analysis of virus-cell interaction and protecting efficacy of virus-specific antibodies and sera. However, they demonstrate limited sensitivity towards many viruses, and require significant volumes of viruses, erythrocytes, sera, and antibodies. The present invention comprises new and significantly more sensitive versions of the HA and HAI assays based on observing agglutination on activated surfaces of specifically opsonized plates and ELISA plates rather than in solution. A version of the new assay that uses ELISA plates additionally allows characterizing the affinity of functional antibodies in the tested sera and fluids, which is not possible in the classical HAI assay. The methods of the present invention can also be used to improve the sensitivity of agglutination methods based on latex beads and to develop agglutination methods using target cells other than erythrocytes.

    摘要翻译： 血细胞凝集（HA）和血细胞凝集抑制（HAI）功能测定仍然是分析病毒 - 细胞相互作用和保护病毒特异性抗体和血清功效的重要手段。 然而，它们对许多病毒的敏感性有限，并且需要大量的病毒，红细胞，血清和抗体。 本发明包括基于观察特异性调理板和ELISA板的活化表面上的凝集而不是在溶液中的HA和HAI测定的新的和显着更敏感的版本。 使用ELISA板的新测定版本另外允许表征所测试的血清和液体中功能性抗体的亲和力，这在经典的HAI测定中是不可能的。 本发明的方法也可用于提高基于乳胶珠的凝集方法的灵敏度，并且使用除了红细胞以外的靶细胞产生凝集方法。